ConductScience.org, home

Paper1978483

Neuropharmacological and behavioural properties of remoxipride in the rat.

Ogren SO and 4 others. Acta Psychiatr Scand Suppl, 1990. Cited by 58 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Neuropharmacological and behavioural properties of remoxipride in the rat. Papers, record 1978483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1978483

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuropharmacological and behavioural properties of remoxipride in the rat.
PubMed
Journal
Acta Psychiatr Scand Suppl
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
58
iCite
Relative citation ratio, by iCite
2.88
iCite
Revised in PubMed
2019-10-22
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ogren SOS O
2Florvall LL
3Hall HH
4Magnusson OO
5Angeby-Möller KK

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
Behavior, AnimalMajor topic
BenzamidesMajor topic
Animals
Arousal
Brain
Dose-Response Relationship, Drug
Extrapyramidal Tracts
Motor Activity
Rats
Receptors, Dopamine
Receptors, Dopamine D2
Remoxipride

Source PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.

PMIDTitleJournalYearIn PapersSource
11,607,043Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist.CNS Drug Rev2001https://conductscience.org/library/papers/11607043PubMed
8,736,614Adverse effects of antipsychotic agents. Do newer agents offer advantages?Drugs1996https://conductscience.org/library/papers/8736614PubMed
8,329,149Tolerability of remoxipride in the long term treatment of schizophrenia. An overview.Drug Saf1993https://conductscience.org/library/papers/8329149PubMed
8,217,058Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8217058PubMed
8,123,230Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8123230PubMed
8,099,797Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8099797PubMed
7,855,196Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile.Psychopharmacology (Berl)1994https://conductscience.org/library/papers/7855196PubMed
7,536,945Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.Psychopharmacology (Berl)1995https://conductscience.org/library/papers/7536945PubMed
1,981,869Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.Drugs1990https://conductscience.org/library/papers/1981869PubMed
1,531,593Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain.J Neural Transm Gen Sect1992https://conductscience.org/library/papers/1531593PubMed
1,450,186A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.J Psychiatry Neurosci1992https://conductscience.org/library/papers/1450186PubMed
1,437,502Dealing with sadness, madness and hostility. New psychotropic drug remedies for the future.Pharm Weekbl Sci1992https://conductscience.org/library/papers/1437502PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1978483

GET https://conductscience.org/api/papers/v1/1978483/authors